Oncomed Pharma (OMED)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2018 | 12-2017 | 12-2016 | 12-2015 | 12-2014 | |
| Sales | 44,421 | 38,154 | 25,153 | 25,899 | 39,559 |
| Gross Profit | 44,421 | 38,154 | 25,153 | 25,899 | 39,559 |
| Operating Expenses | 54,466 | 79,127 | 128,540 | 111,456 | 90,183 |
| Operating Income | -10,045 | -40,973 | -103,387 | -85,557 | -50,624 |
| Other Income | 1,562 | 828 | 299 | 170 | 105 |
| Pre-tax Income | -8,483 | -40,145 | -103,088 | -85,387 | -50,519 |
| Income Tax | -382 | -1,083 | 14 | 20 | -509 |
| Net Income Continuous | -8,101 | -39,062 | -103,102 | -85,407 | -50,010 |
| Net Income | $-8,101 | $-39,062 | $-103,102 | $-85,407 | $-50,010 |
| EPS Basic Total Ops | -0.21 | -1.04 | -3.14 | -2.84 | -1.69 |
| EPS Basic Continuous Ops | -0.21 | -1.04 | -3.14 | -2.84 | -1.69 |
| EPS Diluted Total Ops | -0.21 | -1.04 | -3.14 | -2.84 | -1.69 |
| EPS Diluted Continuous Ops | -0.21 | -1.04 | -3.14 | -2.84 | -1.69 |
| EPS Diluted Before Non-Recurring Items | -0.16 | -1.04 | -3.72 | -1.07 | -1.69 |
| EBITDA(a) | $-8,354 | $-39,263 | $-101,623 | $-83,914 | $-49,194 |